Key Highlights
•
A ketone body called β-hydroxybutyrate (BHB), which is produced during a ketogenic diet, can supercharge CAR T cells, a type of cancer immunotherapy, by improving their energy production and ability to fight tumors. This suggests that a simple dietary supplement could make these powerful cancer treatments more effective for patients.
Source →
•
In early embryos, the structures that help divide the cell’s contents (microtubule asters) are naturally unstable, but different animal species have evolved unique ways to stabilize them. This discovery explains how life ensures the first crucial steps of development happen correctly across the tree of life.
Source →
•
In pancreatic cancer driven by the MYC gene, cancer cells rely heavily on a nutrient-sensing protein called MondoA to coordinate their growth and stress responses. Targeting this dependency could open up new treatment strategies for this difficult-to-treat cancer.
Source →
•
A new computational method shows that when genes are duplicated in lung tumors, the extra copies can evolve new functions, potentially helping the cancer adapt and survive. This reveals a hidden layer of how tumors evolve their complexity and resistance to treatments.
Source →
•
Researchers have identified two proteins, RAD23A and USP13, that control the clumping of TDP-43, a key event in the neurodegenerative disease ALS. Blocking these proteins reduces toxic clumps and improves symptoms in lab models, pointing to promising new drug targets.
Source →
Stay curious. Stay informed — with
Science Briefing.
Always double check the original article for accuracy.
